Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Two Dose Series of High-Dose Influenza Vaccine Is Associated with Longer Duration of Serologic Immunity in Patients with Plasma Cell Disorders

Andrew Branagan, MD, Eamon Duffy, Connor Foster, Rakesh Verma, PhD, Lin Zhang, PhD, Geliang Gan, PhD, Fangyong Li, PhD, Madhav V Dhodapkar, MBBS

Blood (2017) 130 (Supplement 1): 438.

https://doi.org/10.1182/blood.V130.Suppl_1.438.438

Published: 2017

Journal Articles

Long Term Responses to Fludarabine and Rituximab in Waldenstrom’s Macroglobulinemia

Steven Treon, MD, PhD, Andrew Branagan, Leukothea Ioakimidis, PhD, Jacob Soumerai, Christopher Patterson, MD, Parveen Wasi, MD, FRCP(C), Christos Emmanouilides, MD, PhD, Stanley R. Frankel, MD, T. Andrew Lister, MD, Pierre Morel, MD, Jeffrey Matous, MD, Stephanie A. Gregory, MD, Eva K. Kimby, MD, PhD

Blood (2008) 112 (11): 3057.

https://doi.org/10.1182/blood.V112.11.3057.3057

Published: 2008

Journal Articles

Predictive Factors for Response and Progression after Treatment with Rituximab in Previously Untreated Patients with Waldenstrom’s Macroglobulinemia (WM).

Athanasios Anagnostopoulos, MD, Steven P. Treon, MD, Konstantinos Zervas, MD, Andrew Branagan, MD, Dimitra Gika, Athanasios Zomas, MD, Marie Christine Kyrtsonis, MD, Amalia Vassou, MD, Nikolaos Anagnostopoulos, MD, Gerasimos Pangalis, MD, Meletios A. Dimopoulos, MD

Blood (2005) 106 (11): 3485.

https://doi.org/10.1182/blood.V106.11.3485.3485

Published: 2005

Journal Articles

A Novel Functional Role for Soluble CD27 in the Pathogenesis of Waldenstrom’s Macroglobulinemia.

Allen W. Ho, Xavier Leleu, MD, Evdoxia Hatjiharissi, MD, Olivier Tournilhac, MD, Lian Xu, Kelly O’Connor, Robert Manning, Daniel Santos, MD, Mariana Chemaly, MD, Andrew Branagan, Zachary Hunter, Christopher Patterson, Kenneth C. Anderson, MD, Steven P. Treon, MD, PhD

Blood (2005) 106 (11): 4701.

https://doi.org/10.1182/blood.V106.11.4701.4701

Published: 2005

Journal Articles

Establishment of a Waldenstrom’s Macroglobulinemia Cell Line (BCWM.1) with Productive In Vivo Engraftment in SCID-hu Mice.

Blood (2005) 106 (11): 979.

https://doi.org/10.1182/blood.V106.11.979.979

Published: 2005

Journal Articles

Vascular Endothelial Growth Factor (VEGF) Is a Growth and Survival Factor in Waldenstrom’s Macroglobulinemia.

Oliver Tournilhac, Steven Le Gouill, Daniel Ditzel Santos, Klaus Podar, Lian Xu, Evdoxia Hatjiharissi, Yu-Tzu Tai, Zachary Hunter, Andrew Branagan, Kenneth C. Anderson, Steven P. Treon

Blood (2004) 104 (11): 4892.

https://doi.org/10.1182/blood.V104.11.4892.4892

Published: 2004

Journal Articles

IgA and IgG Hypogammaglobulinemia Persists in Most Patients with Waldenstrom’s Macroglobulinemia Despite Therapeutic Responses, Including Complete Remissions.

Steven Treon, Andrew Branagan, Zachary Hunter, Daniel Ditzel Santos, Olivier Tournilhac, Evdoxia Hatjiharissi, Lian Xu, Robert Manning

Blood (2004) 104 (11): 4896.

https://doi.org/10.1182/blood.V104.11.4896.4896

Published: 2004

Journal Articles

Constitutive Expression of CD40L on Bone Marrow Mast Cells Supports the Growth of Lymphoplasmacytic Cells in Patients with Waldenstrom’s Macroglobulinemia.

Olivier Tournilhac, Daniel Ditzel Santos, Lian Xu, Jeffery Kutok, Yu Tsu Tai, Steven Le Gouill, Evdoxia Hatjiharissi, Laurie Catley, Zachary Hunter, Andrew Branagan, Kenneth C. Anderson, Steven P. Treon

Blood (2004) 104 (11): 2350.

https://doi.org/10.1182/blood.V104.11.2350.2350

Published: 2004

Journal Articles

CD52 Is Expressed on Human Mast Cells and Is a Therapeutic Target for the Anti-CD52 Monoclonal Antibody Campath-1H in Waldenstrom’s Macroglobulinemia and Mast Cell Disorders.

Daniel Ditzel Santos, Evdoxia Hatjiarissi, Olivier Tournilhac, Lian Xu, Andrew Branagan, Zachary Hunter, Mayan Catsells, Kenneth C. Anderson, Steven P. Treon

Blood (2004) 104 (11): 4885.

https://doi.org/10.1182/blood.V104.11.4885.4885

Published: 2004

Journal Articles

Clinical Responses to Sildenafil in Waldenstrom’s Macroglobulinemia.

Steven P. Treon, Olivier Tournilhac, Andrew Branagan, Zachary Hunter, Lian Xu, Evdoxia Hatjiharissi, Daniel Ditzel Santos

Blood (2004) 104 (11): 4926.

https://doi.org/10.1182/blood.V104.11.4926.4926

Published: 2004

Journal Articles

Lymphoplasmacytic Cells and Mast Cells Are Targets for Imatinib Mesylate (Gleevec, Glivec) in Waldenstrom’s Macroglobulinemia.

Olivier Tournilhac, Daniel Ditzel Santos, Lian Xu, Evdoxia Hatjiharissi, Yu Tsu, Tai, Laurie Catley, Zachary Hunter, Andrew Branagan, Renate Burger, Reshma Shringarpure, Joshua Boyce, Kenneth C. Anderson, Steven P. Treon

Blood (2004) 104 (11): 4929.

https://doi.org/10.1182/blood.V104.11.4929.4929

Published: 2004

Journal Articles

CHOP Plus Rituximab (CHOP-R) in Waldenström’s Macroglobulinemia (WM).

Zachary Hunter, Andrew Branagan, Steven Treon

Blood (2004) 104 (11): 4930.

https://doi.org/10.1182/blood.V104.11.4930.4930

Published: 2004

Journal Articles

Thalidomide and Rituximab in Waldenström’s Macroglobulinemia.

Andrew Branagan, Zachary Hunter, Daniel Ditzel Santos, Steven P. Treon

Blood (2004) 104 (11): 1484.

https://doi.org/10.1182/blood.V104.11.1484.1484

Published: 2004

Journal Articles

Combination Therapy with Rituximab and Fludarabine in Waldenstrom’s Macroglobulinemia.

Steven P. Treon, Andrew Branagan, Parveen Wasi, Christos A. Emmanouilides, Stanley R. Frankel, Andrew Lister, Pierre Morel, Jeffrey Matous, Sari Heitner Enschede, Eva Kimby

Blood (2004) 104 (11): 753.

https://doi.org/10.1182/blood.V104.11.753.753

Published: 2004

Journal Articles

B-Lymphocyte Stimulator Protein (BLYS) Is Expressed by Bone Marrow Mast and Lymphoplasmacytic Cells in Waldenstrom’s Macroglobulinemia, and Provides Signaling for Growth, Survival and IgM Secretion.

Daniel Ditzel Santos, Olivier Tournilhac, Lian Xu, Hatjiharrisi Evdoxia, Zachary Hunter, Andrew Branagan, Robert Manning, Kenneth C. Anderson, Iqbal Grewal, Steven P. Treon

Blood (2004) 104 (11): 3358.

https://doi.org/10.1182/blood.V104.11.3358.3358

Published: 2004

NARROW

Two Dose Series of High-Dose Influenza Vaccine Is Associated with Longer Duration of Serologic Immunity in Patients with Plasma Cell Disorders

Long Term Responses to Fludarabine and Rituximab in Waldenstrom’s Macroglobulinemia

Predictive Factors for Response and Progression after Treatment with Rituximab in Previously Untreated Patients with Waldenstrom’s Macroglobulinemia (WM).

A Novel Functional Role for Soluble CD27 in the Pathogenesis of Waldenstrom’s Macroglobulinemia.

Establishment of a Waldenstrom’s Macroglobulinemia Cell Line (BCWM.1) with Productive In Vivo Engraftment in SCID-hu Mice.

Vascular Endothelial Growth Factor (VEGF) Is a Growth and Survival Factor in Waldenstrom’s Macroglobulinemia.

IgA and IgG Hypogammaglobulinemia Persists in Most Patients with Waldenstrom’s Macroglobulinemia Despite Therapeutic Responses, Including Complete Remissions.

Constitutive Expression of CD40L on Bone Marrow Mast Cells Supports the Growth of Lymphoplasmacytic Cells in Patients with Waldenstrom’s Macroglobulinemia.

CD52 Is Expressed on Human Mast Cells and Is a Therapeutic Target for the Anti-CD52 Monoclonal Antibody Campath-1H in Waldenstrom’s Macroglobulinemia and Mast Cell Disorders.

Clinical Responses to Sildenafil in Waldenstrom’s Macroglobulinemia.

Lymphoplasmacytic Cells and Mast Cells Are Targets for Imatinib Mesylate (Gleevec, Glivec) in Waldenstrom’s Macroglobulinemia.

CHOP Plus Rituximab (CHOP-R) in Waldenström’s Macroglobulinemia (WM).

Thalidomide and Rituximab in Waldenström’s Macroglobulinemia.

Combination Therapy with Rituximab and Fludarabine in Waldenstrom’s Macroglobulinemia.

B-Lymphocyte Stimulator Protein (BLYS) Is Expressed by Bone Marrow Mast and Lymphoplasmacytic Cells in Waldenstrom’s Macroglobulinemia, and Provides Signaling for Growth, Survival and IgM Secretion.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only